Home News Within3 Insights Management Platform Announcement
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Within3 Insights Management Platform Announcement

by jcp
Editorial & Advertiser disclosure

Within3 Reimagines Life Science Communications to Address Insight Gaps with Industry-first, Holistic Platform 

Within3 Select, Connect, and Discover follow strategic path creating the Insights Management Platform

September 15, 2021 (Cleveland, Oh. and London, UK) – Within3’s hybrid engagement platform is proven to increase the volume, quality, and value of insights generated by life science innovators, their key opinion leaders, patients, and other stakeholders. That’s why multidisciplinary teams in the largest pharmaceutical and medical device companies use Within3 to run engagement programs like advisory boards, congress huddles, and publication planning.

Thousands of engagements revealed pain points across life science teams – data disseminated in disparate locations or silos, void of input from the most appropriate stakeholders – leaving the need for well-informed, fast answers to guide strategies unfilled.

The result is the insight gap: a problem that leads companies to base decisions on old or incomplete data, wasting billions of dollars and years of work.

Solving the Insight Gap at Every Stage of the Product Development Lifecycle

Within3 Select, Connect and Discover combine insights gathered from each phase of the product life cycle on platform to identify the right people, engage them and deliver answers. It solves the insights gap at every stage of the product development lifecycle, from planning, recruiting, and engaging to analyzing, product launch, and beyond.

Within3 Select identifies the right physicians, patients, stakeholders, key industry leaders, and associated experts, for the right problem at the right time.

Within3 Connect is a better way for pharmaceutical, medtech and life sciences companies to converse with the people who matter most. It’s a hybrid communication platform that gives stakeholders the freedom to engage anytime, anywhere, on any connected device. It provides an environment that prioritizes participant schedules.

Life science innovators using Connect regularly report substantial gains in KOL participation, actionable insights and acceleration of regulatory submissions, responses or guideline publication.

Within3 Discover consolidates insights gathered across the enterprise and in the field into one place. Proprietary AI-powered natural language processing enables life science companies to understand key concepts, scientific trends, and sentiment, unlocking answers that drive positive business outcomes.

“As it stands today, the process of gathering insights, let alone the right ones, can take months. In that time a great deal can happen to compromise the information obtained, making it outdated or obsolete and driving up cost with each iteration,” says Within3 CEO Lance Hill. “With multiple systems from different vendors in each phase of the process, teams are faced with inconsistent outcomes, and ultimately, very isolated execution tactics as opposed to a cohesive strategy.”

More than ever, global enterprises, especially life science organizations, need insights from the right experts to work effectively and efficiently in a dynamic marketplace where in-person access is not assured and speed-to-market is critical to success.

The Within3 Insights Management Platform provides precisely this.

Follow Within3 on LinkedIn and Twitter.


You may also like